Bayesian Capital Management’s Ingredion INGR Stock Holding History

Bayesian Capital Management’s Portfolio INGR Stock Details INGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-6,300	Closed	-$854K	–	663
2025 Q2	$854K	Buy	+6,300	New	+$851K	0.14%	205
2025 Q1	–	Sell	-3,200	Closed	-$440K	–	777
2024 Q4	$440K	Buy	+3,200	New	+$450K	0.05%	394
2023 Q1	–	Sell	-4,035	Closed	-$395K	–	938
2022 Q4	$395K	Buy	+4,035	New	+$372K	0.06%	412
2020 Q4	–	Sell	-7,896	Closed	-$598K	–	556
2020 Q3	$598K	Buy	7,896 +596	+8%	+$48.4K	0.15%	187
2020 Q2	$606K	Sell	7,300 -2,100	-22%	-$172K	0.13%	215
2020 Q1	$710K	Buy	9,400 +1,800	+24%	+$155K	0.15%	202
2019 Q4	$706K	Buy	+7,600	New	+$639K	0.12%	229
2017 Q1	–	Sell	-4,352	Closed	-$544K	–	542
2016 Q4	$544K	Buy	+4,352	New	+$550K	0.14%	289
2016 Q3	–	Sell	-3,881	Closed	-$502K	–	424
2016 Q2	$502K	Buy	3,881 +81	+2%	+$9.43K	0.3%	117
2016 Q1	$406K	Buy	+3,800	New	+$379K	0.38%	79

Other funds holding INGR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

YAM

Yacktman Asset Management Austin, Texas $8.09B AUM 19.03% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Bayesian Capital Management's INGR Position: Q3 2025 in Review

Bayesian Capital Management sold out of Ingredion (INGR) in Q3 2025, closing a stake of 6,300 shares — an estimated $854K sold.

Bayesian Capital Management first reported a position in INGR in Q1 2016 and held it in 10 quarters. The position peaked at $854K in Q2 2025. 651 funds tracked by Wall St. Rank hold INGR as of Q3 2025.

Bayesian Capital Management reported no remaining Ingredion position as of Q3 2025 after selling out during the quarter.
Bayesian Capital Management sold 6,300 Ingredion shares in Q3 2025, an estimated $854K.
Bayesian Capital Management first reported a position in Ingredion in Q1 2016 and held it in 10 quarters.
Bayesian Capital Management's Ingredion position peaked at $854K in Q2 2025.
651 funds tracked by Wall St. Rank held Ingredion as of Q3 2025.

Based on Bayesian Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.